Compare · CDXS vs IFF
CDXS vs IFF
Side-by-side comparison of Codexis Inc. (CDXS) and International Flavors & Fragrances Inc. (IFF): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CDXS and IFF operate in Major Chemicals (Industrials), so they compete in similar markets.
- IFF is the larger of the two at $18.54B, about 78.3x CDXS ($236.8M).
- Over the past year, CDXS is up 9.0% and IFF is down 7.1% - CDXS leads by 16.1 points.
- IFF has been more active in the news (4 items in the past 4 weeks vs 1 for CDXS).
- IFF has more recent analyst coverage (25 ratings vs 12 for CDXS).
- Company
- Codexis Inc.
- International Flavors & Fragrances Inc.
- Price
- $2.60+2.36%
- $72.72-0.40%
- Market cap
- $236.8M
- $18.54B
- 1M return
- +0.39%
- -7.05%
- 1Y return
- +9.01%
- -7.06%
- Industry
- Major Chemicals
- Major Chemicals
- Exchange
- NASDAQ
- NYSE
- IPO
- 2010
- News (4w)
- 1
- 4
- Recent ratings
- 12
- 25
Codexis Inc.
Codexis, Inc. discovers, develops, and sells biocatalysts. It offers intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver protein engineering technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations. The company's platform is used to discover novel biotherapeutic drug candidates for targeted human diseases, as well as for molecular biology and in vitro diagnostic enzymes. Its platform also enhances the pharmaceuticals companies manufacturing productivity and efficiency or outsourcing the manufacture of the intermediates and active pharmaceutical ingredients. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. Codexis, Inc. was founded in 2002 and is headquartered in Redwood City, California.
International Flavors & Fragrances Inc.
International Flavors & Fragrances Inc., together with its subsidiaries, manufactures and sells cosmetic active and natural health ingredients for use in various consumer products in Europe, Africa, the Middle East, Greater Asia, North America, and Latin America. It operates through four segments: Nourish, Scent, Health & Biosciences, and Pharma Solutions. The Nourish segment offers flavor compounds; savory solutions, such as marinades or powder blends of flavors, natural colors, seasonings, functional ingredients, and natural anti-oxidants; and inclusions. It also provides nutrition and specialty ingredients primarily consist of natural health ingredients, natural food protection products, and natural colors and flavor ingredients. The Scent segment provides fragrance compounds, which include fine fragrances comprising perfumes and colognes, as well as consumer fragrances; fragrance ingredients comprising synthetic and natural ingredients that could be combined with other materials to create fragrance and consumer compounds; and cosmetic active ingredients consisting of active and functional ingredients, botanicals, and delivery systems to support its customers' cosmetic and personal care product lines. The Health & Biosciences segment develops and produces enzymes, food cultures, probiotics, and specialty ingredients. The Pharma Solutions segment produces and sells cellulosics and alginates-based pharma excipients. The company sells its products primarily to manufacturers of perfumes and cosmetics, hair and other personal care products, soaps and detergents, cleaning products, dairy, meat and other processed foods, beverages, snacks and savory foods, sweet and baked goods, dietary supplements, infant and elderly nutrition, functional food, and pharmaceutical and oral care products. International Flavors & Fragrances Inc. was founded in 1833 and is headquartered in New York, New York.
Latest CDXS
- Codexis highlights stereochemistry advances for scalable RNA manufacturing at TIDES USA
- SEC Form 10-Q filed by Codexis Inc.
- Codexis Inc. filed SEC Form 8-K: Results of Operations and Financial Condition
- Codexis Reports First Quarter 2026 Financial Results
- Codexis to share RNA manufacturing advances at TIDES USA
- SEC Form DEFA14A filed by Codexis Inc.
- SEC Form DEF 14A filed by Codexis Inc.
- Codexis to Report First Quarter 2026 Financial Results on May 7
- SEC Form 8-K filed by Codexis Inc.
- Amendment: SEC Form SCHEDULE 13G/A filed by Codexis Inc.
Latest IFF
- Director Fribourg Paul J bought $20,317,854 worth of shares (273,500 units at $74.29), increasing direct ownership by 46% to 43,150 units (SEC Form 4)
- SEC Form 8-K filed by International Flavors & Fragrances Inc.
- IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC
- LMR by IFF Inaugurates New Experimental Field in Grasse
- IFF Opens Vanilla Innovation Center in Madagascar
- LMR Naturals to Showcase Leadership in Natural Ingredients at SIMPPAR, the International Exhibition of Raw Materials for Perfumery
- President, Scent Teles De Mendonca Ana Paula converted options into 708 shares and covered exercise/tax liability with 362 shares, increasing direct ownership by 6% to 5,718 units (SEC Form 4)
- EVP, Global Operations Officer Finzel Ralf converted options into 1,326 shares and covered exercise/tax liability with 734 shares, increasing direct ownership by 3% to 17,621 units (SEC Form 4)
- EVP, CFO Deveau Michael converted options into 884 shares and covered exercise/tax liability with 452 shares, increasing direct ownership by 3% to 14,024 units (SEC Form 4)
- EVP, Chief Ppl&Culture Officer Borg Deborah converted options into 1,768 shares and covered exercise/tax liability with 713 shares, increasing direct ownership by 3% to 37,925 units (SEC Form 4)